Third Rock Ventures
Tracked across 4 events · 74 articles · First seen May 05, 2026 · Last active Sep 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Third Rock Ventures is a venture capital firm involved in the oncology program. The study's positive results could enhance the value of its investment.
Aug 20, 2026 · 6 articles
Business
Lisata Therapeutics acquired Marea Therapeutics, a clinical-stage biotechnology company developing next-generation medicines for cardioendocrine diseases, in a stock-for-stock transaction. All of Marea's outstanding equity interests were exchanged for 1,793,129 shares of Lisata common stock and…
Impact: Participated in the oversubscribed private placement financing.
Sep 17, 2026 · 6 articles
Business
Impact: Claire Mazumdar previously worked at Third Rock Ventures, contributing to company creation and business development initiatives.
May 05, 2026 · 40 articles
Business
Impact: Third Rock Ventures co-led Merida's Series A financing and will benefit financially from the acquisition.
Aug 31, 2026 · 22 articles
30
Third Rock Ventures participated in financing Lisata TherapeuticsLisata Acquires Marea,...
ERGEN INTELLIGENCE
Track Third Rock Ventures live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard